| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 13 |
| 1 | PALBOCICLIB | 9 |
| 2 | ACETAMINOPHEN | 6 |
| 3 | CONJUGATED ESTROGENS | 6 |
| 4 | DIAZEPAM | 6 |
| 5 | DIAZEPAM ORAL | 6 |
| 6 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 6 |
| 7 | ESTROGENS, CONJUGATED | 6 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 5 |
| 9 | CAPECITABINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-PHENYLALANINE | 1 | 0.0127 |
| 1 | HISTAMINE | 1 | 0.0069 |
| 2 | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE | 1 | 0.0011 |
| 3 | ELAGOLIX | 3 | 0.0008 |
| 4 | SENNA LAXATIVE | 1 | 0.0008 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 6 | GLUTATHIONE | 1 | 0.0006 |
| 7 | CLOMIPRAMINE HYDROCHLORIDE | 2 | 0.0004 |
| 8 | PRASTERONE | 1 | 0.0004 |
| 9 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 1 | Benzodiazepine [EPC] | 11 |
| 2 | Estrogen [EPC] | 9 |
| 3 | Kinase Inhibitor [EPC] | 9 |
| 4 | Expectorant [EPC] | 6 |
| 5 | Alkylating Drug [EPC] | 5 |
| 6 | Aromatase Inhibitor [EPC] | 5 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 8 | Progestin [EPC] | 5 |
| 9 | Progestin-containing Intrauterine System [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 2 | Cannabinoid [EPC] | 1 | 0.0001 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 5 | Sympathomimetic-like Agent [EPC] | 2 | 0.0001 |
| 6 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 7 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 9 | Estrogen [EPC] | 9 | 0.0000 |